Brief: Ono Pharmaceutical Settled Antibody-Related Patent Litigation With Astrazeneca, To Receive About $140 Million
25/07/2023 24:50
July 25 (Reuters) - Ono Pharmaceutical Co Ltd 4528.T :
* ONO PHARMACEUTICAL: SETTLED ANTIBODY-RELATED PATENT LITIGATION WITH
ASTRAZENECA,
TO RECEIVE ABOUT $140 MILLION
Source text for Eikon: ID:
Further company coverage: 4528.T
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours